Glenmark Launches TEVIMBRA® in India, Marking Entry into Immuno-Oncology Space
Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical company, has officially launched TEVIMBRA® (tislelizumab) in India, following approval from the Central […]
